Ciprofloxacin Excretion
Ciprofloxacin is eliminated primarily through renal excretion (40-50% as unchanged drug in urine), with significant additional clearance through hepatic metabolism and biliary/transintestinal elimination. 1
Primary Excretion Pathways
Renal Excretion (Predominant Route)
- Approximately 40-50% of an oral dose is excreted unchanged in the urine 1
- The renal clearance of ciprofloxacin is approximately 300 mL/minute, which substantially exceeds the normal glomerular filtration rate of 120 mL/minute 1
- Active tubular secretion plays a significant role in renal elimination, as evidenced by renal clearance exceeding glomerular filtration 1, 2
- Urinary excretion is virtually complete within 24 hours after dosing 1
- After a 250 mg oral dose, urine concentrations typically exceed 200 μg/mL during the first two hours and remain approximately 30 μg/mL at 8-12 hours post-dose 1
- In healthy volunteers, renal clearance accounts for 66.6% of total serum clearance, with net tubular secretion contributing substantially 2
Non-Renal Clearance Pathways
- Approximately 20-35% of an oral dose is recovered in feces within 5 days, arising from biliary clearance or transintestinal elimination 1
- Hepatic metabolism accounts for approximately 15% of the dose, producing four metabolites with varying antimicrobial activity 1
- Bile concentrations are several-fold higher than serum concentrations, though only a small amount (1-2%) is recovered as unchanged drug or metabolites 1
Excretion in Renal Impairment
Dosing Adjustments Required
- For creatinine clearance 30-50 mL/min: reduce to 250-500 mg every 12 hours 1
- For creatinine clearance 5-29 mL/min: reduce to 250-500 mg every 18 hours 1
- For hemodialysis or peritoneal dialysis patients: 250-500 mg every 24 hours (administered after dialysis) 1
- In anephric patients, serum clearance is approximately 50% of normal subjects, necessitating maximal dose reduction of 50% when creatinine clearance falls to 20-30 mL/min/1.73 m² 2
Pharmacokinetic Changes in Renal Dysfunction
- The elimination half-life is only slightly prolonged (~20%) in renal impairment, increasing from approximately 4 hours to 4-5 hours 1, 2
- Plasma clearance correlates with creatinine clearance, while non-renal clearance remains independent of renal function 3
- Alternative pathways of elimination (hepatic metabolism and biliary/intestinal clearance) partially compensate for reduced renal excretion 1
- Renal clearance of ciprofloxacin correlates strongly with creatinine clearance (rs = 0.93, P < 0.001) 3
Clinical Considerations
Drug Interactions Affecting Excretion
- Co-administration of probenecid reduces ciprofloxacin renal clearance by approximately 50% and increases systemic circulation concentrations by 50% 1, 2
- This interaction confirms that active tubular secretion is a major component of renal elimination 2
Monitoring in Renal Impairment
- Patients with severe infections and severe renal impairment may receive 750 mg at adjusted intervals, but require careful monitoring 1
- The reduced dose should be administered every 12 hours despite variability in terminal half-life in renal impairment 2
Dialysis Considerations
- Ciprofloxacin is not significantly removed by hemodialysis due to high molecular weight, wide tissue distribution, high protein binding (20-40%), and rapid hepatic metabolism 4, 1
- Supplemental dosing after hemodialysis is not necessary 4
- Administering the drug after dialysis facilitates directly observed therapy and prevents premature drug removal 4